Literature DB >> 19748629

Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities.

Marco Sparaco1, Laura Maria Gaeta, Filippo Maria Santorelli, Chiara Passarelli, Giulia Tozzi, Enrico Bertini, Alessandro Simonati, Francesco Scaravilli, Franco Taroni, Charles Duyckaerts, Michele Feleppa, Fiorella Piemonte.   

Abstract

Friedreich's ataxia (FRDA) is an autosomal recessive disorder caused by mutations in the gene encoding frataxin, a mitochondrial protein implicated in iron metabolism. Current evidence suggests that loss of frataxin causes iron overload in tissues, and increase in free-radical production leading to oxidation and inactivation of mitochondrial respiratory chain enzymes, particularly Complexes I, II, III and aconitase. Glutathione plays an important role in the detoxification of ROS in the Central Nervous System (CNS), where it also provides regulation of protein function by glutathionylation. The cytoskeletal proteins are particularly susceptible to oxidation and appear constitutively glutathionylated in the human CNS. Previously, we showed loss of cytoskeletal organization in fibroblasts of patients with FRDA found to be associated with increased levels of glutathione bound to cytoskeletal proteins. In this study, we analysed the glutathionylation of proteins in the spinal cord of patients with FRDA and the distribution of tubulin and neurofilaments in the same area. We found, for the first time, a significant rise of the dynamic pool of tubulin as well as abnormal distribution of the phosphorylated forms of human neurofilaments in FRDA motor neurons. In the same cells, the cytoskeletal abnormalities co-localized with an increase in protein glutathionylation and the mitochondrial proteins were normally expressed by immunocytochemistry. Our results suggest that in FRDA oxidative stress causes abnormally increased protein glutathionylation leading to prominent abnormalities of the neuronal cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748629     DOI: 10.1016/j.jns.2009.08.052

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  38 in total

1.  A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.

Authors:  Marguerite V Evans-Galea; Louise A Corben; Justin Hasell; Charles A Galea; Michael C Fahey; Desirée du Sart; Martin B Delatycki
Journal:  Neurogenetics       Date:  2011-08-10       Impact factor: 2.660

2.  Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.

Authors:  Mariana Igoillo-Esteve; Ana F Oliveira; Cristina Cosentino; Federica Fantuzzi; Céline Demarez; Sanna Toivonen; Amélie Hu; Satyan Chintawar; Miguel Lopes; Nathalie Pachera; Ying Cai; Baroj Abdulkarim; Myriam Rai; Lorella Marselli; Piero Marchetti; Mohammad Tariq; Jean-Christophe Jonas; Marina Boscolo; Massimo Pandolfo; Décio L Eizirik; Miriam Cnop
Journal:  JCI Insight       Date:  2020-01-30

Review 3.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

4.  Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia.

Authors:  Rimi Dey; Kevin Kemp; Elizabeth Gray; Claire Rice; Neil Scolding; Alastair Wilkins
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 5.  An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation.

Authors:  Jie Zhang; Zhi-Wei Ye; Shweta Singh; Danyelle M Townsend; Kenneth D Tew
Journal:  Free Radic Biol Med       Date:  2018-03-23       Impact factor: 7.376

Review 6.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

7.  Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.

Authors:  Jiun-I Lai; Daniel Nachun; Lina Petrosyan; Benjamin Throesch; Erica Campau; Fuying Gao; Kristin K Baldwin; Giovanni Coppola; Joel M Gottesfeld; Elisabetta Soragni
Journal:  J Biol Chem       Date:  2018-12-14       Impact factor: 5.157

8.  Current and emerging treatment options in the management of Friedreich ataxia.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Anna Choub; Gabriele Siciliano
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

9.  Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.

Authors:  Yuxi Shan; Robert A Schoenfeld; Genki Hayashi; Eleonora Napoli; Tasuku Akiyama; Mirela Iodi Carstens; Earl E Carstens; Mark A Pook; Gino A Cortopassi
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 10.  Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.

Authors:  Rachael A Vaubel; Grazia Isaya
Journal:  Mol Cell Neurosci       Date:  2012-08-11       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.